 Abeona Therapeutics NASDAQ:ABEOs stock had its buy rating reaffirmed by equities researchers at HC Wainwright in a report issued on Monday, AnalystRatings.com reports. They presently have a 11.00 target price on the biopharmaceutical companys stock. HC Wainwrights target price suggests a potential upside of 265.45 from the stocks current price. ABEO has been the subject ... 